NASDAQ: ZYBT
Zhengye Biotechnology Holding Ltd Stock Ownership - Who owns Zhengye Biotechnology Holding?

Insider buying vs selling

Have Zhengye Biotechnology Holding Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ZYBT insiders and whales buy or sell their stock.

ZYBT Shareholders

What type of owners hold Zhengye Biotechnology Holding Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Xtx Topco Ltd0.09%44,146$36.64kInstitution
Winton Group Ltd0.07%33,389$27.71kInstitution
Geode Capital Management LLC0.06%29,068$24.13kInstitution
Ubs Group Ag0.02%8,036$6.67kInstitution
Tower Research Capital LLC Trc0.01%4,912$4.08kInstitution
Royal Bank Of Canada 10.00%1,230$1.02kInstitution
Morgan Stanley0.00%261$216.63Institution
Caitong International Asset Management Co Ltd0.00%1$0.83Institution

1 of 1

ZYBT vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZYBT0.26%0.00%
SCYX76.46%23.54%Net Buying
TLPH29.50%70.50%Net BuyingNet Selling
IXHL2.83%97.17%
INCR1.10%27.14%

Zhengye Biotechnology Holding Stock Ownership FAQ

Who owns Zhengye Biotechnology Holding?

Zhengye Biotechnology Holding (NASDAQ: ZYBT) is owned by 0.26% institutional shareholders, 0.00% Zhengye Biotechnology Holding insiders, and 99.74% retail investors. Xtx Topco Ltd is the largest individual Zhengye Biotechnology Holding shareholder, owning 44,146.00 shares representing 0.09% of the company. Xtx Topco Ltd's Zhengye Biotechnology Holding shares are currently valued at $36.64k.

If you're new to stock investing, here's how to buy Zhengye Biotechnology Holding stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.